Peter Marynen

26.5k total citations · 3 hit papers
289 papers, 14.9k citations indexed

About

Peter Marynen is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Peter Marynen has authored 289 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Molecular Biology, 87 papers in Genetics and 61 papers in Hematology. Recurrent topics in Peter Marynen's work include Genomic variations and chromosomal abnormalities (46 papers), Chronic Myeloid Leukemia Treatments (46 papers) and Lymphoma Diagnosis and Treatment (35 papers). Peter Marynen is often cited by papers focused on Genomic variations and chromosomal abnormalities (46 papers), Chronic Myeloid Leukemia Treatments (46 papers) and Lymphoma Diagnosis and Treatment (35 papers). Peter Marynen collaborates with scholars based in Belgium, United States and Germany. Peter Marynen's co-authors include Herman Van den Berghe, Jan Cools, Mathijs Baens, Iwona Włodarska, Anne Hagemeijer, Nicole Mentens, Peter Van Loo, Christiane De Wolf‐Peeters, Guy Froyen and Joris Vermeesch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Peter Marynen

285 papers receiving 14.5k citations

Hit Papers

Gene prioritization through genomic data fusion 1999 2026 2008 2017 2006 2010 1999 200 400 600

Peers

Peter Marynen
Comparison fields: 5 of 153
  • Molecular Biology 6.8k
  • Genetics 3.1k
  • Hematology 2.6k
  • Oncology 2.3k
  • Pathology and Forensic Medicine 2.2k
Replace Ad Geurts van Kessel with:
Ad Geurts van Kessel Netherlands
Denise Sheer United Kingdom
Yoshiaki Ito Japan
Terence H. Rabbitts United Kingdom
Seishi Ogawa Japan
Karl V. Voelkerding United States
Peter Besmer United States
John Groffen United States
Jeffrey H. Miner United States
Michael L. Cleary United States
Ad Geurts van Kessel Netherlands View profile →
Citations per field, relative to Peter Marynen
Peter Marynen · 1×
Citations per year, relative to Peter Marynen
Peter Marynen · 1×

Countries citing papers authored by Peter Marynen

Since Specialization
Citations

This map shows the geographic impact of Peter Marynen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Marynen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Marynen more than expected).

Fields of papers citing papers by Peter Marynen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Marynen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Marynen. The network helps show where Peter Marynen may publish in the future.

Co-authorship network of co-authors of Peter Marynen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Marynen. A scholar is included among the top collaborators of Peter Marynen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Marynen. Peter Marynen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 33
2 68
3
A novel t(4;9)(q21;p24) fuses SEC31A to JAK2 in nodular-sclerosis Hodgkin lymphoma
2
4 58
5 92
6
Functional characterization of the T-ALL associated EML1-ABL1 and NUP214-ABL1 oncogenes
1
7 57
8
Duplication of the MECP2 region is a frequent cause of severe mental retardation and neurological symptoms in males
1
9
Molecular karkyotyping detecs structural low grade mosaics in 4 % of patietns with idiopathic mental retardation and multiple congenital aberrations
2
10
Micro-array CGH analysis of 4p microdeletions refines the genotype-phenotype map of the region and pinpoints low copy repeats as susceptibility sites for terminal chromosomal deletions
0
11
The TET RNA-binding proteins, EWSR1 and TAF15, are involved in acute lymphoblastic leukemia, through fusion with a new transcription factor, CIZ/NMP4
2
12
Molecular characterization of a t(2;3)(p23;q26): A recurrent translocation involving the EVI1 gene
2
13
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive ALK tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis
2
14
Fusion between the apoptosis inhibitor gene AP12 and a novel 18q gene MLT , rearranged in the t(11,18)(q21;q21), marks half of the gastro-intestinal MALT type lymphomas without large cell proliferation
4
15
Telomere length regulation in telomerase positive murine cell line
1
16 213
17
Identification and characterisation of BTL, a new fusion partner of ETV6 in 1 T-ALL case and 2 AML cases with a translocation t(4;12) (q11;p13)
1
18
A form of non-specific mental retardation is probably caused by a microdeletion in a Belgian family
12
19
FISH analysis of typical t(5;12) (q32;p12) and variant t(10;12)(q23;p12) translocation in four patients with chronic myeloid disorders
4
20 18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026